@inbook{e8de2680a4164fd1adbbc01ea7cb4815,
title = "Treatment of Advanced and Recurrent Carcinoma: Hormonal Therapy",
abstract = "Progestins were the first drugs to be used in systemic therapy of endometrial cancer. After four decades of clinical trials, their role has been narrowed to a relatively small percentage of tumors that have metastasized but are well differentiated and rich in hormonal receptors. Nevertheless, with better selection of patients likely to benefit from hormonal therapy and the exploration of potential role after chemotherapy, one may look forward to new directions of interest.",
keywords = "Endometrial cancer, Hormone receptors, Progestins",
author = "Franco Muggia and Blank, \{Stephanie V.\}",
note = "Publisher Copyright: {\textcopyright} Humana Press, a part of Springer Science+Business Media, LLC 2009.",
year = "2009",
doi = "10.1007/978-1-60327-044-1\_11",
language = "English",
series = "Current Clinical Oncology",
publisher = "Springer International Publishing",
pages = "217--222",
booktitle = "Current Clinical Oncology",
}